Loading…

Development of COVID-19 severity assessment score in adults presenting with COVID-19 to the emergency department

Critically-ill Covid-19 patients require extensive resources which can overburden a healthcare system already under strain due to a pandemic. A good disease severity prediction score can help allocate resources to where they are needed most. We developed a Covid-19 Severity Assessment Score (CoSAS)...

Full description

Saved in:
Bibliographic Details
Published in:BMC infectious diseases 2022-06, Vol.22 (1), p.1-576, Article 576
Main Authors: Subhani, Faysal, Chhotani, Abdul Ahad, Waheed, Shahan, Zahid, Rana Osama, Azizi, Kiran, Buksh, Ahmed Raheem
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c608t-147edc16d3b316b9d45792a4e45007a332ab60cb6067138bf5c0e730ac2c100d3
cites cdi_FETCH-LOGICAL-c608t-147edc16d3b316b9d45792a4e45007a332ab60cb6067138bf5c0e730ac2c100d3
container_end_page 576
container_issue 1
container_start_page 1
container_title BMC infectious diseases
container_volume 22
creator Subhani, Faysal
Chhotani, Abdul Ahad
Waheed, Shahan
Zahid, Rana Osama
Azizi, Kiran
Buksh, Ahmed Raheem
description Critically-ill Covid-19 patients require extensive resources which can overburden a healthcare system already under strain due to a pandemic. A good disease severity prediction score can help allocate resources to where they are needed most. We developed a Covid-19 Severity Assessment Score (CoSAS) to predict those patients likely to suffer from mortalities within 28 days of hospital admission. We also compared this score to Quick Sequential Organ Failure Assessment (qSOFA) in adults. CoSAS includes the following 10 components: Age, gender, Clinical Frailty Score, number of comorbidities, Ferritin level, D-dimer level, neutrophil/lymphocyte ratio, C-reactive Protein levels, systolic blood pressure and oxygen saturation. Our study was a single center study with data collected via chart review and phone calls. 309 patients were included in the study. CoSAS proved to be a good score to predict Covid-19 mortality with an Area under the Curve (AUC) of 0.78. It also proved better than qSOFA (AUC of 0.70). More studies are needed to externally validate CoSAS. CoSAS is an accurate score to predict Covid-19 mortality in the Pakistani population.
doi_str_mv 10.1186/s12879-022-07535-8
format article
fullrecord <record><control><sourceid>gale_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_e41b6aa685e64d9bb800eddb710842bc</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A708474186</galeid><doaj_id>oai_doaj_org_article_e41b6aa685e64d9bb800eddb710842bc</doaj_id><sourcerecordid>A708474186</sourcerecordid><originalsourceid>FETCH-LOGICAL-c608t-147edc16d3b316b9d45792a4e45007a332ab60cb6067138bf5c0e730ac2c100d3</originalsourceid><addsrcrecordid>eNqNkstu1DAUhiMEoqXwAqwssYFFii9J7GyQqimXkSqNxKVby7FPMh4lcbCdwrw9npmKEsQCWZat4-_8Psf-s-wlwZeEiOptIFTwOseU5piXrMzFo-ycFJzklLHi8R_7s-xZCDuMCRe0fpqdsZJXhNT8PJuu4Q56Nw0wRuRatNrcrq9zUqOQ4t7GPVIhQAjH86CdB2RHpMzcx4AmDyHF7dihHzZuH5KjQ3ELCAbwHYx6jwxMyseDyPPsSav6AC_u14vs24f3X1ef8pvNx_Xq6ibXFRYxT6WD0aQyrGGkampTlLymqoCixJgrxqhqKqzTrDhhomlLjYEzrDTVBGPDLrL1Sdc4tZOTt4Pye-mUlceA851MFVndg4SCNJVSlSihKkzdNAJjMKbhBIuCNjppvTtpTXMzpLJSG171C9HlyWi3snN3sqaspJwngdf3At59nyFEOdigoe_VCG4OklaCCMLqsk7oq7_QnZv9mJ4qUTUpCE-f90B1KjVgx9ale_VBVF7xVDUvkkESdfkPKg0Dg9VuhNam-CLhzSIhMRF-xk7NIcj1l8__z25ulyw9sdq7EDy0v9-OYHnwsjx5WSYvy6OXpWC_ACl84fk</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2691417357</pqid></control><display><type>article</type><title>Development of COVID-19 severity assessment score in adults presenting with COVID-19 to the emergency department</title><source>Publicly Available Content Database (Proquest) (PQ_SDU_P3)</source><source>PubMed Central</source><source>Coronavirus Research Database</source><creator>Subhani, Faysal ; Chhotani, Abdul Ahad ; Waheed, Shahan ; Zahid, Rana Osama ; Azizi, Kiran ; Buksh, Ahmed Raheem</creator><creatorcontrib>Subhani, Faysal ; Chhotani, Abdul Ahad ; Waheed, Shahan ; Zahid, Rana Osama ; Azizi, Kiran ; Buksh, Ahmed Raheem</creatorcontrib><description>Critically-ill Covid-19 patients require extensive resources which can overburden a healthcare system already under strain due to a pandemic. A good disease severity prediction score can help allocate resources to where they are needed most. We developed a Covid-19 Severity Assessment Score (CoSAS) to predict those patients likely to suffer from mortalities within 28 days of hospital admission. We also compared this score to Quick Sequential Organ Failure Assessment (qSOFA) in adults. CoSAS includes the following 10 components: Age, gender, Clinical Frailty Score, number of comorbidities, Ferritin level, D-dimer level, neutrophil/lymphocyte ratio, C-reactive Protein levels, systolic blood pressure and oxygen saturation. Our study was a single center study with data collected via chart review and phone calls. 309 patients were included in the study. CoSAS proved to be a good score to predict Covid-19 mortality with an Area under the Curve (AUC) of 0.78. It also proved better than qSOFA (AUC of 0.70). More studies are needed to externally validate CoSAS. CoSAS is an accurate score to predict Covid-19 mortality in the Pakistani population.</description><identifier>ISSN: 1471-2334</identifier><identifier>EISSN: 1471-2334</identifier><identifier>DOI: 10.1186/s12879-022-07535-8</identifier><identifier>PMID: 35761197</identifier><language>eng</language><publisher>London: BioMed Central Ltd</publisher><subject>Adults ; Blood pressure ; C-reactive protein ; Care and treatment ; Comorbidity ; Coronaviruses ; COVID-19 ; Data collection ; Diagnosis ; Disease transmission ; Emergency ; Emergency medical care ; Emergency medical services ; Emergency service ; Ferritin ; Health risk assessment ; Hospitals ; Intensive care ; Laboratories ; Leukocytes (neutrophilic) ; Low income groups ; Lymphocytes ; Males ; Measurement ; Methods ; Mortality ; Oxygen content ; Pandemics ; Patients ; Pneumonia ; Prediction score ; qSOFA ; Variables ; Viremia</subject><ispartof>BMC infectious diseases, 2022-06, Vol.22 (1), p.1-576, Article 576</ispartof><rights>COPYRIGHT 2022 BioMed Central Ltd.</rights><rights>2022. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>The Author(s) 2022</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c608t-147edc16d3b316b9d45792a4e45007a332ab60cb6067138bf5c0e730ac2c100d3</citedby><cites>FETCH-LOGICAL-c608t-147edc16d3b316b9d45792a4e45007a332ab60cb6067138bf5c0e730ac2c100d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9235277/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2691417357?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,25753,27924,27925,37012,37013,38516,43895,44590,53791,53793</link.rule.ids></links><search><creatorcontrib>Subhani, Faysal</creatorcontrib><creatorcontrib>Chhotani, Abdul Ahad</creatorcontrib><creatorcontrib>Waheed, Shahan</creatorcontrib><creatorcontrib>Zahid, Rana Osama</creatorcontrib><creatorcontrib>Azizi, Kiran</creatorcontrib><creatorcontrib>Buksh, Ahmed Raheem</creatorcontrib><title>Development of COVID-19 severity assessment score in adults presenting with COVID-19 to the emergency department</title><title>BMC infectious diseases</title><description>Critically-ill Covid-19 patients require extensive resources which can overburden a healthcare system already under strain due to a pandemic. A good disease severity prediction score can help allocate resources to where they are needed most. We developed a Covid-19 Severity Assessment Score (CoSAS) to predict those patients likely to suffer from mortalities within 28 days of hospital admission. We also compared this score to Quick Sequential Organ Failure Assessment (qSOFA) in adults. CoSAS includes the following 10 components: Age, gender, Clinical Frailty Score, number of comorbidities, Ferritin level, D-dimer level, neutrophil/lymphocyte ratio, C-reactive Protein levels, systolic blood pressure and oxygen saturation. Our study was a single center study with data collected via chart review and phone calls. 309 patients were included in the study. CoSAS proved to be a good score to predict Covid-19 mortality with an Area under the Curve (AUC) of 0.78. It also proved better than qSOFA (AUC of 0.70). More studies are needed to externally validate CoSAS. CoSAS is an accurate score to predict Covid-19 mortality in the Pakistani population.</description><subject>Adults</subject><subject>Blood pressure</subject><subject>C-reactive protein</subject><subject>Care and treatment</subject><subject>Comorbidity</subject><subject>Coronaviruses</subject><subject>COVID-19</subject><subject>Data collection</subject><subject>Diagnosis</subject><subject>Disease transmission</subject><subject>Emergency</subject><subject>Emergency medical care</subject><subject>Emergency medical services</subject><subject>Emergency service</subject><subject>Ferritin</subject><subject>Health risk assessment</subject><subject>Hospitals</subject><subject>Intensive care</subject><subject>Laboratories</subject><subject>Leukocytes (neutrophilic)</subject><subject>Low income groups</subject><subject>Lymphocytes</subject><subject>Males</subject><subject>Measurement</subject><subject>Methods</subject><subject>Mortality</subject><subject>Oxygen content</subject><subject>Pandemics</subject><subject>Patients</subject><subject>Pneumonia</subject><subject>Prediction score</subject><subject>qSOFA</subject><subject>Variables</subject><subject>Viremia</subject><issn>1471-2334</issn><issn>1471-2334</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>COVID</sourceid><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNqNkstu1DAUhiMEoqXwAqwssYFFii9J7GyQqimXkSqNxKVby7FPMh4lcbCdwrw9npmKEsQCWZat4-_8Psf-s-wlwZeEiOptIFTwOseU5piXrMzFo-ycFJzklLHi8R_7s-xZCDuMCRe0fpqdsZJXhNT8PJuu4Q56Nw0wRuRatNrcrq9zUqOQ4t7GPVIhQAjH86CdB2RHpMzcx4AmDyHF7dihHzZuH5KjQ3ELCAbwHYx6jwxMyseDyPPsSav6AC_u14vs24f3X1ef8pvNx_Xq6ibXFRYxT6WD0aQyrGGkampTlLymqoCixJgrxqhqKqzTrDhhomlLjYEzrDTVBGPDLrL1Sdc4tZOTt4Pye-mUlceA851MFVndg4SCNJVSlSihKkzdNAJjMKbhBIuCNjppvTtpTXMzpLJSG171C9HlyWi3snN3sqaspJwngdf3At59nyFEOdigoe_VCG4OklaCCMLqsk7oq7_QnZv9mJ4qUTUpCE-f90B1KjVgx9ale_VBVF7xVDUvkkESdfkPKg0Dg9VuhNam-CLhzSIhMRF-xk7NIcj1l8__z25ulyw9sdq7EDy0v9-OYHnwsjx5WSYvy6OXpWC_ACl84fk</recordid><startdate>20220627</startdate><enddate>20220627</enddate><creator>Subhani, Faysal</creator><creator>Chhotani, Abdul Ahad</creator><creator>Waheed, Shahan</creator><creator>Zahid, Rana Osama</creator><creator>Azizi, Kiran</creator><creator>Buksh, Ahmed Raheem</creator><general>BioMed Central Ltd</general><general>BioMed Central</general><general>BMC</general><scope>AAYXX</scope><scope>CITATION</scope><scope>IOV</scope><scope>ISR</scope><scope>3V.</scope><scope>7QL</scope><scope>7T2</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8C1</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>C1K</scope><scope>CCPQU</scope><scope>COVID</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20220627</creationdate><title>Development of COVID-19 severity assessment score in adults presenting with COVID-19 to the emergency department</title><author>Subhani, Faysal ; Chhotani, Abdul Ahad ; Waheed, Shahan ; Zahid, Rana Osama ; Azizi, Kiran ; Buksh, Ahmed Raheem</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c608t-147edc16d3b316b9d45792a4e45007a332ab60cb6067138bf5c0e730ac2c100d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Adults</topic><topic>Blood pressure</topic><topic>C-reactive protein</topic><topic>Care and treatment</topic><topic>Comorbidity</topic><topic>Coronaviruses</topic><topic>COVID-19</topic><topic>Data collection</topic><topic>Diagnosis</topic><topic>Disease transmission</topic><topic>Emergency</topic><topic>Emergency medical care</topic><topic>Emergency medical services</topic><topic>Emergency service</topic><topic>Ferritin</topic><topic>Health risk assessment</topic><topic>Hospitals</topic><topic>Intensive care</topic><topic>Laboratories</topic><topic>Leukocytes (neutrophilic)</topic><topic>Low income groups</topic><topic>Lymphocytes</topic><topic>Males</topic><topic>Measurement</topic><topic>Methods</topic><topic>Mortality</topic><topic>Oxygen content</topic><topic>Pandemics</topic><topic>Patients</topic><topic>Pneumonia</topic><topic>Prediction score</topic><topic>qSOFA</topic><topic>Variables</topic><topic>Viremia</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Subhani, Faysal</creatorcontrib><creatorcontrib>Chhotani, Abdul Ahad</creatorcontrib><creatorcontrib>Waheed, Shahan</creatorcontrib><creatorcontrib>Zahid, Rana Osama</creatorcontrib><creatorcontrib>Azizi, Kiran</creatorcontrib><creatorcontrib>Buksh, Ahmed Raheem</creatorcontrib><collection>CrossRef</collection><collection>Opposing Viewpoints in Context (Gale)</collection><collection>Gale In Context: Science</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Health and Safety Science Abstracts (Full archive)</collection><collection>Virology and AIDS Abstracts</collection><collection>ProQuest Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Public Health Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>Coronavirus Research Database</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Publicly Available Content Database (Proquest) (PQ_SDU_P3)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>Directory of Open Access Journals</collection><jtitle>BMC infectious diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Subhani, Faysal</au><au>Chhotani, Abdul Ahad</au><au>Waheed, Shahan</au><au>Zahid, Rana Osama</au><au>Azizi, Kiran</au><au>Buksh, Ahmed Raheem</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Development of COVID-19 severity assessment score in adults presenting with COVID-19 to the emergency department</atitle><jtitle>BMC infectious diseases</jtitle><date>2022-06-27</date><risdate>2022</risdate><volume>22</volume><issue>1</issue><spage>1</spage><epage>576</epage><pages>1-576</pages><artnum>576</artnum><issn>1471-2334</issn><eissn>1471-2334</eissn><abstract>Critically-ill Covid-19 patients require extensive resources which can overburden a healthcare system already under strain due to a pandemic. A good disease severity prediction score can help allocate resources to where they are needed most. We developed a Covid-19 Severity Assessment Score (CoSAS) to predict those patients likely to suffer from mortalities within 28 days of hospital admission. We also compared this score to Quick Sequential Organ Failure Assessment (qSOFA) in adults. CoSAS includes the following 10 components: Age, gender, Clinical Frailty Score, number of comorbidities, Ferritin level, D-dimer level, neutrophil/lymphocyte ratio, C-reactive Protein levels, systolic blood pressure and oxygen saturation. Our study was a single center study with data collected via chart review and phone calls. 309 patients were included in the study. CoSAS proved to be a good score to predict Covid-19 mortality with an Area under the Curve (AUC) of 0.78. It also proved better than qSOFA (AUC of 0.70). More studies are needed to externally validate CoSAS. CoSAS is an accurate score to predict Covid-19 mortality in the Pakistani population.</abstract><cop>London</cop><pub>BioMed Central Ltd</pub><pmid>35761197</pmid><doi>10.1186/s12879-022-07535-8</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1471-2334
ispartof BMC infectious diseases, 2022-06, Vol.22 (1), p.1-576, Article 576
issn 1471-2334
1471-2334
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_e41b6aa685e64d9bb800eddb710842bc
source Publicly Available Content Database (Proquest) (PQ_SDU_P3); PubMed Central; Coronavirus Research Database
subjects Adults
Blood pressure
C-reactive protein
Care and treatment
Comorbidity
Coronaviruses
COVID-19
Data collection
Diagnosis
Disease transmission
Emergency
Emergency medical care
Emergency medical services
Emergency service
Ferritin
Health risk assessment
Hospitals
Intensive care
Laboratories
Leukocytes (neutrophilic)
Low income groups
Lymphocytes
Males
Measurement
Methods
Mortality
Oxygen content
Pandemics
Patients
Pneumonia
Prediction score
qSOFA
Variables
Viremia
title Development of COVID-19 severity assessment score in adults presenting with COVID-19 to the emergency department
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T19%3A51%3A20IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Development%20of%20COVID-19%20severity%20assessment%20score%20in%20adults%20presenting%20with%20COVID-19%20to%20the%20emergency%20department&rft.jtitle=BMC%20infectious%20diseases&rft.au=Subhani,%20Faysal&rft.date=2022-06-27&rft.volume=22&rft.issue=1&rft.spage=1&rft.epage=576&rft.pages=1-576&rft.artnum=576&rft.issn=1471-2334&rft.eissn=1471-2334&rft_id=info:doi/10.1186/s12879-022-07535-8&rft_dat=%3Cgale_doaj_%3EA708474186%3C/gale_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c608t-147edc16d3b316b9d45792a4e45007a332ab60cb6067138bf5c0e730ac2c100d3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2691417357&rft_id=info:pmid/35761197&rft_galeid=A708474186&rfr_iscdi=true